These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12177388)

  • 1. Neuropathologic findings in a Guillain-Barré patient with strokes after IVIg therapy.
    Byrne NP; Henry JC; Herrmann DN; Abdelhalim AN; Shrier DA; Francis CW; Powers JM
    Neurology; 2002 Aug; 59(3):458-61. PubMed ID: 12177388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posterior reversible encephalopathy syndrome during intravenous immunoglobulin therapy in Guillain-Barré syndrome].
    Watanabe E; Ido N; Saito T; Kato H; Terashi H; Aizawa H
    Rinsho Shinkeigaku; 2021 Jan; 61(1):12-17. PubMed ID: 33328417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    Doss-Esper CE; Singhal AB; Smith MS; Henderson GV
    J Neuroimaging; 2005 Apr; 15(2):188-92. PubMed ID: 15746232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and prognosis of Guillain-Barré syndrome].
    Mitsui T; Nomura K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():381-7. PubMed ID: 26480729
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome.
    Steinberger B; Coleman TA
    Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Images in emergency medicine. Winged scapula as the presenting symptom of Guillain-Barre syndrome.
    Sivan M; Hassan A
    Emerg Med J; 2009 Nov; 26(11):790. PubMed ID: 19850802
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravenous immunoglobulin in children with Guillain-Barré syndrome].
    Bruck I; Antoniuk SA; Cat R; Spessatto A; Halick SM; Bruyn LR; Rodrigues M; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1081-91. PubMed ID: 11105076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing Guillain Barré Syndrome and nephrotic syndrome secondary to focal segmental glomerulosclerosis.
    Souayah N; Cros D; Stein TD; Chong PS
    J Neurol Sci; 2008 Jul; 270(1-2):184-8. PubMed ID: 18325535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome].
    Lavrnić D; Romić M; Kacar A; Stojanović-Rakocević V; Stević Z; Vujić A; Basta I; Marjanović I; Bogdanović G; Apostolski S
    Vojnosanit Pregl; 2006 Jan; 63(1):37-42. PubMed ID: 16471247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of Guillain-Barré syndrome with meningeal irritation.
    Ashikari Y; Kobayashi S; Tago A; Yoneyama M; Ito M; Fukuda K; Mizuno Y; Tsunoda Y; Shimizu S; Yokoi K; Kamioka N; Hamajima N; Suzuki S
    Brain Dev; 2016 Jan; 38(1):163-6. PubMed ID: 26403311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome.
    Rosca EC; Rosca O; Simu M
    Int Immunopharmacol; 2015 Dec; 29(2):964-965. PubMed ID: 26428850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
    Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
    No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barré syndrome with central nervous system symptoms. Report of two cases].
    Łabuz-Roszak B; Pierzchała K; Kapustecki J; Biernawska J; Mańka I; Kumor K
    Neurol Neurochir Pol; 2004; 38(3):221-6. PubMed ID: 15354236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guillain-Barré syndrome. What should be done, when the treatment appears to fail?].
    Tellería-Díaz A
    Rev Neurol; 2003 Oct 16-31; 37(8):798-800. PubMed ID: 14593645
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare case of Guillain-Barre syndrome with pregnancy.
    Vijayaraghavan J; Vasudevan D; Sadique N; Rajeswari KS; Pondurangi M; Jayshree
    J Indian Med Assoc; 2006 May; 104(5):269-70. PubMed ID: 17058576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
    Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
    Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS).
    Shalman A; Savir S; Mechnik Steen Y; Ovanyan A; Boniel N; Koyfman L; Bichovsky Y; Zlotnik A; Klein M; Brotfain E
    J Clin Neurosci; 2020 Apr; 74():247-249. PubMed ID: 32088107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.